Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy

Tue, 06/11/2019 - 12:00

Cell Rep.

Accession number

31189114

Volume

27(11):3315-3330.e7. doi: 10.1016/j.celrep.2019.05.041

Authors short

Celis-Gutierrez J.

Authors

Celis-Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Grégoire C, Ounoughene Y, Fiore F, Aebersold R, Roncagalli R, Gstaiger M, Malissen B.

URL

https://www.ncbi.nlm.nih.gov/pubmed/31189114